Legal mentions
Mentions Légales
Avis de Pratiques de Confidentialité
Adrienne Loth, PhD, LMFT, CST
1800 VINE ST STE 100 Los Angeles, CA 90028
Tél : 530.316.4248
7 Avenue Pierre Grenier, Boulogne-Billancourt, France 92100,
Tél : 530.316.4248
Date d'entrée en vigueur : 16 février 2026
CET AVIS DÉCRIT COMMENT LES INFORMATIONS MÉDICALES VOUS CONCERNANT PEUVENT ÊTRE UTILISÉES ET DIVULGUÉES ET COMMENT VOUS POUVEZ ACCÉDER À CES INFORMATIONS. VEUILLEZ LE LIRE ATTENTIVEMENT.
Nos obligations légales
La loi nous oblige à :
-
Maintenir la confidentialité et la sécurité de vos informations de santé protégées (PHI).
-
Vous fournir cet avis de pratiques de confidentialité.
-
Respecter les termes de l'avis actuellement en vigueur.
-
Vous informer à la suite d'une violation de vos PHI non sécurisées.
Utilisation et divulgation de vos informations
-
Pour le traitement : Nous pouvons utiliser et divulguer vos PHI pour fournir, coordonner ou gérer vos soins de santé et les services connexes. Cela inclut le partage d'informations avec d'autres prestataires de soins impliqués dans votre suivi.
-
Pour le paiement : Nous utilisons vos PHI pour obtenir le paiement des services fournis, y compris la facturation des compagnies d'assurance et la vérification de la couverture.
-
Pour les opérations de santé : Nous pouvons utiliser vos PHI pour les opérations nécessaires au fonctionnement de notre cabinet, à l'amélioration de la qualité des soins et à la réalisation d'audits.
-
Requis par la loi : Nous pouvons divulguer vos PHI lorsque la loi fédérale, étatique ou locale l'exige (par exemple, pour des activités de santé publique ou en réponse à des ordonnances judiciaires).
Protections spéciales pour les troubles liés à l'utilisation de substances (42 CFR Part 2)
Les dossiers qui vous identifient comme ayant ou ayant eu un trouble lié à l'utilisation de substances (SUD) bénéficient d'une protection supplémentaire en vertu de la réglementation fédérale Part 2.
-
Règle générale : Nous ne pouvons pas utiliser ou divulguer ces dossiers sans votre consentement écrit, sauf autorisation ou obligation légale.
-
Consentement unique : Vous pouvez fournir un consentement écrit unique pour l'utilisation et la divulgation de ces dossiers à des fins de traitement, de paiement et d'opérations de santé.
-
Interdiction de divulgation ultérieure : Toute divulgation au titre de la Part 2 inclut une mention interdisant au destinataire de divulguer à nouveau ces informations sans votre consentement explicite.
Vos droits concernant vos informations
-
Droit d'accès : Vous avez le droit d'inspecter et d'obtenir une copie de vos PHI et de vos dossiers Part 2.
-
Droit de rectification : Vous pouvez demander une modification de vos PHI si vous estimez qu'elles sont incorrectes ou incomplètes.
-
Droit à la restriction : Vous pouvez demander des restrictions sur certaines utilisations et divulgations de vos informations.
-
Droit de porter plainte : Si vous estimez que vos droits à la vie privée ont été violés, vous pouvez déposer une plainte auprès de notre responsable de la protection de la vie privée ou du ministère américain de la Santé et des Services sociaux sans crainte de représailles.
Coordonnées
Pour toute question concernant cet avis ou vos droits, veuillez contacter :
Responsable de la protection de la vie privée : Adrienne Loth
Téléphone : 310-926-0988
E-mail : adrienne@hashtagtherapy.com
Adrienne Loth, PhD, LMFT, CST
1800 VINE ST STE 100 Los Angeles, CA 90028, P: 530.316.4248
7 Avenue Pierre Grenier, Boulogne-Billancourt, France 92100, P: 530.316.4248
NOTICE OF PRIVACY PRACTICES
Effective Date: February 16, 2026
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
This Notice applies to services provided through our electronic health record and practice management system, including our patient portal, as well as information posted or collected through our website.
Our Legal Duties
We are required by law to:
-
Maintain the privacy and security of your protected health information (PHI);
-
Provide you with this Notice of Privacy Practices;
-
Follow the terms of this Notice currently in effect; and
-
Notify you following a breach of unsecured PHI.
This Notice applies to all records created or received by our practice relating to your care, whether created by clinicians, administrative staff, or business associates acting on our behalf. This includes information maintained in our electronic health record system (including patient portals), billing systems, and website-based forms.
What Is Protected Health Information (PHI)
Protected Health Information (PHI) includes information that identifies you and relates to your past, present, or future physical or mental health condition, the provision of health care to you, or payment for that care.
Certain PHI related to substance use disorder (SUD) diagnosis, treatment, or referral for treatment may also be protected under 42 CFR Part 2 ("Part 2"), which provides additional confidentiality protections beyond HIPAA.
How We May Use and Disclose Your Information
For Treatment
We may use and disclose your PHI to provide, coordinate, or manage your health care and related services. This includes sharing information with other health care providers involved in your care.
For Payment
We may use and disclose your PHI to obtain payment for services provided to you, including billing insurance companies, verifying coverage, and collecting payment.
For Health Care Operations
We may use and disclose your PHI for operations necessary to run our practice, improve the quality of care, conduct audits, and ensure compliance with legal requirements.
Uses and Disclosures Required by Law
We may disclose your PHI when required to do so by federal, state, or local law, including for public health activities, reporting abuse or neglect, or responding to lawful court orders.
Special Protections for Substance Use Disorder Records (42 CFR Part 2)
Records that identify you as having, or having had, a substance use disorder and that are created or maintained in connection with SUD treatment are protected under Part 2.
General Rule
We may not use or disclose Part 2-protected records without your written consent, except as permitted or required by law.
Single Consent for Treatment, Payment, and Health Care Operations
Under updated Part 2 regulations aligned with HIPAA, you may provide a single written consent allowing the use and disclosure of Part 2 records for:
• Treatment
• Payment
• Health care operations
Once disclosed under a valid consent, recipients may further use or disclose the information in accordance with HIPAA, except for use in civil, criminal, administrative, or legislative proceedings against you related to substance use, which is strictly prohibited without a court order.
Prohibition on Re-Disclosure Notice
All Part 2 disclosures include the following statement:
This information has been disclosed to you from records protected by federal confidentiality rules (42 CFR Part 2). The federal rules prohibit you from making any further disclosure unless expressly permitted by the written consent of the individual to whom it pertains or as otherwise permitted by 42 CFR Part 2.
Uses and Disclosures That Require Your Written Authorization
We will obtain your written authorization before using or disclosing your PHI or Part 2 records for purposes such as:
-
Marketing (with limited exceptions);
-
Sale of PHI;
-
Most uses of psychotherapy notes;
-
Disclosures not otherwise described in this Notice.
You may revoke an authorization at any time in writing, except to the extent we have already relied on it.
California Supplement (Applies to California Patients)
In addition to the rights described below, California law provides patients with privacy protections that may be more stringent than federal requirements. Where California law offers greater protection or broader rights regarding your health information, we will comply with California law.
This California Supplement is intended to work in conjunction with HIPAA and 42 CFR Part 2. Nothing in this section reduces or limits the confidentiality protections afforded to substance use disorder records under federal law.
Your Rights Regarding Your Information
Right to Access
You have the right to inspect and obtain a copy of your PHI and Part 2 records, subject to limited exceptions.
Right to Amend
You may request an amendment to your PHI if you believe it is incorrect or incomplete.
Right to an Accounting of Disclosures
You have the right to request a list of certain disclosures of your PHI.
Right to Request Restrictions
You may request restrictions on certain uses and disclosures of your PHI. We are not required to agree to all requests.
Right to Request Confidential Communications
You may request that we communicate with you in a specific way or at a specific location.
Right to File a Complaint
You may file a complaint if you believe your privacy rights have been violated. You will not be retaliated against for filing a complaint.
Complaints may be filed with:
-
Our Privacy Officer;
-
The U.S. Department of Health and Human Services, Office for Civil Rights; or
-
California authorities, including the California Department of Public Health or the California Attorney General's Office.
California law may allow you to pursue remedies for violations of medical privacy rights in addition to federal options.
Breach Notification
We will notify you in accordance with applicable law if a breach of your unsecured PHI or Part 2-protected information occurs.
Changes to This Notice
We reserve the right to change this Notice and make the new Notice effective for all PHI we maintain. Updated Notices will be available upon request and posted in our office and on our website, if applicable.
Electronic Systems and Patient Portal
We use electronic systems to support scheduling, documentation, billing, secure messaging, and record storage. These systems may allow you to view, download, or transmit your health information securely. Access to these systems is governed by unique user credentials and security safeguards consistent with HIPAA and Part 2 requirements.
Communications sent through our patient portal are considered part of your designated record set. While portal messaging is encrypted and secure, you should avoid using unsecured email to communicate sensitive information unless you understand and accept the associated risks.
Website Use and Online Forms
If you submit information through our website (for example, via contact forms, intake forms, or secure portals), that information may become part of your medical record and will be protected in accordance with this Notice.
We do not sell or rent your health information collected through our website.
Contact Information
If you have questions about this Notice or your privacy rights, please contact:
Privacy Officer: Adrienne Loth
Phone: 310-926-0988
Email: adrienne@hashtagtherapy.com
Acknowledgment of Receipt I acknowledge that I have received or had electronic access to the Notice of Privacy
Practices effective February 16, 2026.